ALP (Alkaline Phosphatase)
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- ALP elevation has two major sources in adults — liver and bone — and GGT tells you which one. When ALP is elevated, the most important next step is checking GGT. GGT is produced almost exclusively by the hepatobiliary system and rises when biliary obstruction or liver disease is causing ALP elevation. If GGT is elevated alongside ALP, the liver is the source and further hepatic investigation is indicated. If GGT is normal despite elevated ALP, the bone is the likely source — Paget's disease, bone metastases, hyperparathyroidism, or high bone turnover. This simple rule eliminates much of the diagnostic confusion around isolated ALP elevation.
- ALP reflects cholestatic liver disease specifically — not general liver damage. ALT and AST rise primarily with hepatocellular injury (hepatitis, fatty liver, drug toxicity, ischemia). ALP rises primarily with cholestasis — obstruction of bile flow, either within the liver (intrahepatic cholestasis) or from bile duct obstruction (stones, stricture, malignancy). A pattern of disproportionately elevated ALP relative to ALT/AST is a key signal for biliary disease, primary biliary cholangitis, primary sclerosing cholangitis, or bile duct obstruction. When all three are elevated, mixed hepatocellular and cholestatic injury is present.
- Very low ALP — often overlooked clinically — may be a marker of metabolic dysfunction and is associated with increased all-cause mortality in population studies. Hypophosphatasia (a rare genetic enzymatic condition) produces dramatically low ALP and causes bone fragility and neurological disease. But population studies have found that ALP in the low-normal range (below 40–50 IU/L) in adults without hypophosphatasia is associated with higher cardiovascular and all-cause mortality — possibly reflecting zinc deficiency, hypothyroidism, poor nutritional status, or other metabolic impairments. Low ALP combined with other nutritional markers (low albumin, low zinc) is particularly meaningful.
- ALP completes the liver enzyme panel alongside ALT/AST and GGT. Each liver enzyme reflects a different anatomical compartment and injury type: ALT is most specific for hepatocellular damage; GGT is the most sensitive marker of alcohol-related liver disease and biliary damage; ALP signals the bile canalicular system and biliary tree. Together, the pattern of elevation across these three markers provides a more specific localization of liver pathology than any one alone. The combination of elevated ALP + GGT with normal ALT/AST is the classic pattern of extrahepatic bile duct obstruction.
- Bone disease produces ALP elevation that is often missed because GGT and other liver tests are normal. Paget's disease of bone — a common and underdiagnosed condition in adults over 50, particularly men — produces dramatic ALP elevation (often 3–10× the upper limit of normal) from intense osteoblast activity, while GGT remains normal. Bone metastases, hyperparathyroidism, and vitamin D deficiency-related secondary hyperparathyroidism also elevate ALP through bone-derived isoenzyme. A normal GGT with elevated ALP should prompt bone-focused investigation.
ALP in the Liver Enzyme Pattern
ALP is a component of virtually every standard blood panel, yet it remains one of the most underexplained test results in clinical practice. Patients are told their ALP is elevated without understanding what that means or what to do about it.
The key to interpreting ALP is pattern recognition — not just the absolute number, but which other liver enzymes are elevated alongside it, and by how much. Three patterns cover the majority of clinically important scenarios:
Elevated ALP + elevated GGT, normal or mildly elevated ALT/AST: Classic cholestatic pattern. Something is obstructing or damaging the bile ducts — either inside the liver (intrahepatic cholestasis, primary biliary cholangitis, primary sclerosing cholangitis) or outside it (gallstones, bile duct stricture, pancreatic head pathology). This pattern warrants liver imaging and possibly additional tests for biliary disease.
Elevated ALP + normal GGT, normal ALT/AST: Bone source almost certain. The hepatobiliary system is normal; osteoblast activity is driving the ALP. Investigation should focus on bone metabolism — PTH, calcium, vitamin D, bone-specific ALP, and imaging if Paget's disease or bone metastases are suspected.
Elevated ALP + elevated ALT/AST + elevated GGT: Mixed hepatocellular and cholestatic injury — suggests more diffuse liver disease, drug toxicity, or infiltrative liver pathology. 1
What a Normal CMP ALP Actually Tells You
For most adults without liver or bone symptoms, ALP within the normal range on a routine CMP is a reassuring finding — not a signal to do nothing with, but confirmation that cholestatic liver disease and high-turnover bone disease are not present at a level detectable by this marker.
The informative question for longevity monitoring is where within the normal range the value sits and whether it is trending. ALP slowly declines after the rapid bone growth of adolescence and stabilizes in adulthood, with a slight increase in older adults as bone turnover increases with age-related decline in bone density. A middle-aged adult with ALP in the 70–120 IU/L range and normal GGT, ALT, and AST has a reassuring liver and bone enzyme picture. An adult with ALP progressively rising year over year toward the upper reference limit — while GGT rises in parallel — warrants closer attention to liver health even before any single value becomes definitively abnormal.
| ALP Level | Status | First Diagnostic Step |
|---|---|---|
| < 40 IU/L | Low — investigate | Check zinc, thyroid, nutrition; consider hypophosphatasia |
| 70–120 IU/L | Longevity optimal | No action needed; maintain metabolic health |
| 120–150 IU/L | High-normal | Check GGT; evaluate trends; consider bone vs. liver |
| 150–300 IU/L | Elevated | Check GGT, ALT/AST; hepatic imaging if GGT co-elevated |
| > 300 IU/L | Significantly elevated | Medical evaluation; consider biliary obstruction, Paget's, bone mets |
| Range Type | Value (IU/L) | Notes |
|---|---|---|
| Standard Clinical Range | Adults: 44–147 IU/L (ranges vary by laboratory) | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | 70–120 IU/L |
Associated with reduced all-cause mortality and extended healthspan.
ALP has physiologic variation that makes context essential. ALP is higher in adolescents and children during growth (bone isoenzyme from active osteoblasts), transiently elevated after fatty meals (intestinal isoenzyme in some blood types), and elevated during pregnancy (placental isoenzyme). In adults, persistently elevated ALP above 150–200 IU/L warrants investigation for liver and bone pathology. GGT is the most useful co-marker: GGT elevation alongside ALP confirms hepatobiliary origin; normal GGT with elevated ALP points to bone or non-hepatic source. Very low ALP (< 40–50 IU/L in adults) may indicate hypophosphatasia (a rare genetic condition of reduced ALP), zinc or magnesium deficiency, hypothyroidism, or cardiac bypass surgery effects, and has been associated with increased all-cause mortality in several population studies.
|
Already have your results? See what your ALP (Alkaline Phosphatase) and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
My ALP is mildly elevated but all my other liver tests are normal — what does that mean?
Isolated ALP elevation with normal ALT, AST, and GGT is an important pattern that most commonly points to a bone source rather than liver disease. The liver enzymes ALT, AST, and especially GGT all reflect hepatobiliary pathology — when they are normal, the bile ducts and hepatocytes are functioning normally, and the ALP is most likely coming from bone. The most important bone condition to evaluate in this scenario is Paget's disease of bone (if the elevation is marked), bone metastases (if there is any cancer history), hyperparathyroidism (check calcium and PTH), and vitamin D deficiency-related bone turnover. Transient isolated ALP elevation can also occur after a fatty meal (intestinal isoenzyme, particularly in people with blood type B or O) or after intense exercise (bone isoenzyme from stress on the periosteum). If the elevation is persistent and unexplained by clinical context, an alkaline phosphatase isoenzyme fractionation test can specifically identify the bone versus liver contribution.
What is Paget's disease of bone and why does it elevate ALP so dramatically?
Paget's disease of bone is a chronic metabolic bone disorder characterized by accelerated and disorganized bone remodeling — excessive osteoclastic bone resorption followed by reactive osteoblastic bone formation that is structurally abnormal. It is surprisingly common (approximately 3% of adults over 55 in the United States, higher in people of Northern European descent) and often asymptomatic for years. The intense osteoblast activity of Paget's disease releases massive quantities of bone-derived ALP into the bloodstream — ALP values of 300–1,000+ IU/L are common in active Paget's disease, among the highest ALP values seen outside of biliary obstruction or malignancy. Despite this dramatic enzyme elevation, GGT and other liver tests remain normal, helping confirm the bone origin. Paget's disease is often discovered incidentally on routine blood tests when isolated very high ALP is found. Complications include bone pain, fracture, hearing loss (if the skull is involved), and nerve compression.
Can medications cause elevated ALP?
Yes, a number of medications can elevate ALP through hepatotoxic or cholestatic mechanisms. Common culprits include statins (which can cause a mild cholestatic pattern), antibiotics (particularly amoxicillin-clavulanate, flucloxacillin, and fluoroquinolones), antiepileptic medications (phenytoin, carbamazepine), anabolic steroids (which produce a distinctive cholestatic pattern), oral contraceptives in susceptible individuals, and NSAIDs. Drug-induced ALP elevation is typically accompanied by elevated GGT (confirming hepatobiliary origin) and a review of the temporal relationship with the medication. Statins deserve specific mention in the longevity context — they are widely used and can produce isolated or disproportionate ALP elevation that may cause alarm on routine panels; this is almost always a benign cholestatic pattern rather than hepatocellular injury.
What does low ALP mean and should I be concerned?
Low ALP (below 40–50 IU/L in adults) is less commonly discussed than elevated ALP but is clinically relevant in several contexts. Hypophosphatasia is a rare genetic disorder of ALP enzyme deficiency that causes impaired bone and tooth mineralization, recurrent fractures, and neurological complications — ALP levels in hypophosphatasia are dramatically low (often < 20 IU/L). More commonly, mildly low ALP in adults is associated with zinc or magnesium deficiency (both metals are required for ALP catalytic activity), hypothyroidism, severe anemia, cardiac bypass surgery effects, and nutritional insufficiency. Several population studies have found that ALP in the lowest quartile of the normal range is associated with higher cardiovascular and all-cause mortality, possibly reflecting the metabolic states listed above. Mildly low ALP is worth investigating for zinc status, thyroid function, and overall nutritional markers rather than dismissing as irrelevant.